Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn’s disease of inflammatory type

被引：0
|
作者：
Yutaka Nagata
Motohiro Esaki
Tomohiko Moriyama
Atsushi Hirano
Junji Umeno
Yuji Maehata
Takehiro Torisu
Takayuki Matsumoto
Takanari Kitazono
机构：
[1] Kyushu University,Department of Medicine and Clinical Science, Graduate School of Medical Sciences
[2] Iwate Medical University,Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Crohn’s disease; Intestinal surgery; Anti-TNF therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 338
页数：8
相关论文
共 50 条
  • [1] Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type
    Nagata, Yutaka
    Esaki, Motohiro
    Moriyama, Tomohiko
    Hirano, Atsushi
    Umeno, Junji
    Maehata, Yuji
    Torisu, Takehiro
    Matsumoto, Takayuki
    Kitazono, Takanari
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 330 - 338
  • [2] Anti-Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery
    Herfarth, Hans H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1503 - 1506
  • [3] Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
    Syed, Ali
    Cross, Raymond K.
    Flasar, Mark H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04): : 583 - 593
  • [4] Anti-Tumor Necrosis Factor Therapy in Intestinal Behcet's Disease
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2018, 12 (06) : 623 - 632
  • [5] Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease
    Thomas, CW
    Weinshenker, BG
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (01) : 28 - 31
  • [6] Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen M.
    Chen, Lang
    Xie, Fenglong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1293 - +
  • [7] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [8] Efficacy of restarting anti-tumor necrosis factor alpha agents after surgery in patients with Crohn's disease
    Hiraoka, Sakiko
    Takashima, Shiho
    Kondo, Yoshitaka
    Inokuchi, Toshihiro
    Sugihara, Yuusaku
    Takahara, Masahiro
    Kawano, Seiji
    Harada, Keita
    Kato, Jun
    Okada, Hiroyuki
    INTESTINAL RESEARCH, 2018, 16 (01) : 75 - 82
  • [9] Risk Factors for Surgery in Patients with Intestinal Behcet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
    Han, So Jung
    Kang, Eun Ae
    Park, Jihye
    Park, Soo Jung
    Park, Jae Jun
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    YONSEI MEDICAL JOURNAL, 2023, 64 (02) : 111 - 116
  • [10] Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease
    Umeno, Junji
    Matsumoto, Takayuki
    Jo, Yukihiko
    Ichikawa, Miki
    Urabe, Kazunori
    Lida, Mitsuo
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (09) : 1188 - 1189
12345